BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Mederi Therapeutics Inc.: Stretta(R) Therapy - An Effective and Minimally Invasive Option for Gastric Reflux Disease (GERD) - Launched in the US


4/12/2010 11:09:28 AM

GREENWICH, Conn., April 12 /PRNewswire/ -- Mederi Therapeutics Inc. announces the US release of the Stretta System for treatment of GERD. Stretta Therapy is a minimally invasive procedure that treats a debilitating condition that affects tens of millions of Americans. Stretta Therapy delivers radiofrequency (RF) energy to the muscles of the Lower Esophageal Sphincter (LES), the valve that separates the stomach from the esophagus. Stretta tightens and restores the function of this valve, which in turn reduces or eliminates regurgitation and acid exposure to the esophagus, thus reducing a patient's symptoms of GERD.

Stretta therapy is an outpatient (same day) procedure. Patients go home shortly after the procedure and typically resume normal activities within several days. Stretta clinical studies show a 90 percent patient satisfaction score. Further, recent clinical studies have demonstrated symptom relief lasting at least 4 years.

ABOUT MEDERI

Mederi Therapeutics manufactures and markets innovative medical devices that deliver radiofrequency energy to treat disease states affecting the human digestive system. All Mederi therapies are outpatient, minimally invasive, and promote rapid recovery. Mederi Therapeutics is located in Greenwich, Connecticut.

CONTACT: Sheila Doyle, Manager of Communications and Marketing,
+1-203-930-9980

Web site: http://www.mederitherapeutics.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES